PREMIER MEDICAL CORPORATION PRIVATE LIMITED

Premier Medical Corporation Private Limited is a global leader in developing cost-effective point-of-care rapid diagnostic tests since 1996. The company manufactures and distributes qualitative and semi-quantitative lateral flow assays for infectious disease detection, including malaria, HIV, hepatitis C, and syphilis, as well as emerging tests for COVID-19 and sickle cell disease. Products are marketed under brand names First Response®, Sure Status®, AccuSign®, and AQCheck®. The organization holds WHO Prequalification status for multiple products, ISO 13485:2016 certification, and CE marking compliance. With manufacturing facilities in India and distribution networks spanning 100+ countries across Africa, Europe, Asia, and the Middle East, Premier Medical serves healthcare professionals, laboratories, hospitals, government health centers, and major public health procurement agencies including WHO, The Global Fund, USAID, and UNICEF.